A5055747791- Diabetes Management and Research
- Diabetes Treatment and Management
- Diabetes Management and Education
- Metabolism, Diabetes, and Cancer
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Diet and metabolism studies
- Pharmacology and Obesity Treatment
- Pituitary Gland Disorders and Treatments
- Chronic Disease Management Strategies
- Diabetes and associated disorders
- Obesity and Health Practices
- Retinal Diseases and Treatments
- Growth Hormone and Insulin-like Growth Factors
- Pancreatic function and diabetes
- Retinal Imaging and Analysis
- Hypothalamic control of reproductive hormones
- Mobile Health and mHealth Applications
- Health Systems, Economic Evaluations, Quality of Life
- Obesity, Physical Activity, Diet
- Neuropeptides and Animal Physiology
- Muscle and Compartmental Disorders
- Acute Ischemic Stroke Management
- Adrenal and Paraganglionic Tumors
- Bariatric Surgery and Outcomes
Joslin Diabetes Center
2010-2024
Harvard University
2012-2024
Beth Israel Deaconess Medical Center
2003-2020
Hadassah Medical Center
2015
American Association of Clinical Endocrinologists
2013
Beth Israel Deaconess Hospital
1995
University of Cape Town
1985-1990
Groote Schuur Hospital
1985-1990
Boston Medical Center
1985
Emerging data support bariatric surgery as a therapeutic strategy for management of type 2 diabetes mellitus.To test the feasibility methods to conduct larger multisite trial determine long-term effect Roux-en-Y gastric bypass (RYGB) compared with an intensive medical and weight (Weight Achievement Intensive Treatment [Why WAIT]) program diabetes.A 1-year pragmatic randomized clinical was conducted in academic institution. Participants included persons aged 21 65 years diagnosed more than 1...
Overseeing proper insulin initiation and titration remains a challenging task in diabetes care. Recent advances mobile technology have enabled new models of collaborative care between patients healthcare providers (HCPs). We hypothesized that the adoption such could help individuals starting basal achieve better glycemic control compared with standard clinical practice.
To explore physicians' awareness of and responses to type 2 diabetic patients' social emotional difficulties.We conducted semistructured interviews with 19 physicians. Interviews were transcribed, coded, analyzed using thematic analysis.Three themes emerged: 1) difficulties: physicians recognized the frequency seriousness difficulties; 2) many reported that intervening these difficulties was challenging few treatment options beyond making referrals, individualizing care, recommending more...
Objective Diabetes self-care is challenging and requires effective patient–provider communication to achieve optimal treatment outcomes. This study explored perceptions of barriers facilitators diabetes during medical appointments. Design Qualitative using in-depth interviews with a semistructured interview guide. Participants Thirty-four patients type 2 19 physicians who treat diabetes. Results Physicians described some as reluctant discuss their behaviors primarily because fear being...
OBJECTIVE To assess self-reported awareness of diabetic retinopathy (DR) and concordance eye examination follow-up compared with findings from concurrent retinal images. RESEARCH DESIGN AND METHODS We conducted a prospective observational 10-year study 26,876 consecutive patients diabetes who underwent imaging during an endocrinology visit. Awareness were evaluated using questionnaires imaging. RESULTS information gradable images available in 25,360 (94.3%). Severity DR by was as follows: no...
Since their introduction to clinical practice in the 1950s, sulfonylureas have been widely prescribed for use patients with type 2 diabetes. Of all other medications currently available use, only metformin has used more frequently. However, several new drug classes emerged that are reported equal glucose-lowering efficacy and greater safety when added treatment of whom monotherapy is no longer sufficient. Moreover, current arguments also suggest alternative drugs may be superior regard risk...
Purpose The purpose of this study was to explore physicians’ perceptions the multidisciplinary type 2 diabetes treatment team. Methods Nineteen physicians (74% endocrinologists; 26% primary care) participated in semistructured interviews. Audiorecorded data were transcribed, coded, and analyzed using thematic analysis NVivo 8 software. Results Physicians considered team, including a physician educator, as very important treatment. Participants described how diabetes, with its many...
Type 2 diabetes mellitus is the consequence of both insulin resistance and impaired secretion. In progression from normal glucose tolerance to diabetes, postprandial (PPG) levels often rise before fasting plasma (FPG) increase above 126 mg/dL (7.0 mmol/L). Numerous epidemiologic studies have shown that associated with increased risk for macrovascular disease isolated postchallenge hyperglycemia an independent factor mortality. Reducing microvascular complications by improving glycosylated...
Background: Historically, intensive insulin therapy for type 1 diabetes (T1D) has improved glycemic control at the risk of adverse weight gain. The impact continuous subcutaneous infusion (CSII) on in current era remains unknown. We assessed changes hemoglobin A1c (HbA1c) and adults with T1D transitioning to CSII 2 centers Denmark United States. Methods: Patients T1D, aged ≥18 years, managed multiple daily injections (MDI) who transitioned between 2002 2013 were identified using electronic...